THROMBOEMBOLISM AND ORAL-CONTRACEPTIVES

被引:8
作者
BRIGGS, MH [1 ]
机构
[1] ALFRED HOSP,BIOCHEM DEPT,MELBOURNE,AUSTRALIA
关键词
D O I
10.1136/bmj.2.5917.503-b
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:503 / 503
页数:1
相关论文
共 7 条
[1]   ORAL-CONTRACEPTIVES - THERAPEUTICS VERSUS ADVERSE REACTIONS, WITH AN OUTLOOK FOR FUTURE I [J].
BINGEL, AS ;
BENOIT, PS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (02) :179-200
[2]   ANTI-ESTROGENIC EFFECTS OF PROGESTOGENS IN NORMAL WOMEN [J].
BRIGGS, M .
LIFE SCIENCE PART 1 PHYSIOLOGY & PHARMACOLOGY, 1972, 11 (20) :949-&
[3]   EFFECTS OF SOME CONTRACEPTIVE STEROIDS ON SERUM-PROTEINS OF WOMEN [J].
BRIGGS, M ;
BRIGGS, M .
BIOCHEMICAL PHARMACOLOGY, 1973, 22 (18) :2277-2281
[4]  
BRIGGS MH, 1974, PHARMACOLOGICAL MODE
[5]   THROMBOEMBOLIC DISEASE AND STEROIDAL CONTENT OF ORAL CONTRACEPTIVES - A REPORT TO COMMITTEE ON SAFETY OF DRUGS [J].
INMAN, WHW ;
VESSEY, MP ;
WESTERHOLM, B ;
ENGELUND, A .
BMJ-BRITISH MEDICAL JOURNAL, 1970, 2 (5703) :203-+
[6]   ORAL-CONTRACEPTIVES AND THROMBOEMBOLISM [J].
VESSEY, M ;
DOLL, R .
BRITISH MEDICAL JOURNAL, 1974, 1 (5899) :158-158
[7]  
1974, BRIT MED J, V1, P213